SMOC2 and renal cell carcinoma: Using RCC cell lines ACHN and 786-O, SMOC2 recombinant and enforced expression significantly increased EMT-markers with accompanying EMT-phenotypic and -metastatic features, which were abrogated by SMOC2 siRNA.